期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 53, 期 1, 页码 281-286出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00441-08
关键词
-
资金
- Salix Pharmaceuticals, Inc., Morrisville, NC
Rifaximin, ampicillin-sulbactam, neomycin, nitazoxanide, teicoplanin, and vancomycin were tested against 536 strains of anaerobic bacteria. The overall MIC of rifaximin at which 50% of strains were inhibited was 0.25 mu g/ml. Ninety percent of the strains tested were inhibited by 256 mu g/ml of rifaximin or less, an activity equivalent to those of teicoplanin and vancomycin but less than those of nitazoxanide and ampicillin-sulbactam.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据